Prostate Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Jul-2017
  • Tables : 160
  • Figures : 54
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT58MR
  • Format : ppt

Uncontrollable growth of cells in prostate gland leads to the development of prostate cancer. Several men develop low-grade prostatic intraepithelial neoplasia (PIN), however they don’t necessarily develop prostate cancer. No sure way has been found to prevent prostate cancer, however the chances can be lowered by being physically active and maintaining a healthy weight.

An increasing geriatric population across the developed world along with access to top-quality healthcare is expected to benefit the prostate cancer diagnostics market. Healthcare spending is growing by leaps and bounds both though the government as well as private providers. As per the WHO Health Spending Observatory, the spending on health may rise to US$ 18.2 trillion by the year 2040 with annual growth rates of 3.4% in upper middle income countries and 2.7% in high-income ones. The global prostate cancer diagnostics market is projected to grow to nearly US$ 1.1 billion in 2022.

Market Taxonomy

Test Type

End User

PSA Tests

Hospital Associated Labs

CTC Tests

Independent Diagnostic Laboratories

Immunohistochemistry

Cancer Research Institutes

PCA3 test

Others

Others

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

PCA3 and PSA Test Segment Vital in the Prostate Cancer Diagnostics Market

The PCA3 and PSA test segments can be considered the most important in the prostate cancer diagnostics market as they both represent the highest potential in terms of market opportunity. The PSA segment is anticipated to be worth just over US$ 270 million in 2017 and it should grow at a healthy CAGR during the period 2017-2022. On the other hand, the PCA3 segment is poised to grow to nearly US$ 284 million by the end of the forecast period.

North America is the largest region for both segments and accounts for nearly 2/5th of the prostate cancer diagnostics market. The region’s large geriatric population and high prevalence of cancer mean that demand for prostate cancer diagnostics will continue to remain strong during the forecast period.

Smaller Share of CTC

The CTC segment holds revenue share in the global prostate cancer diagnostics market. This segment is projected to reach US$ 141 million by the end of 2022.

The immunohistochemistry segment is projected to witness a CAGR of 4.5% for the five-year study period. While North America may be the largest regional contributor, key stakeholders could also focus on Europe as it holds a revenue share of more than 30% throughout the period.

Focus on Hospital Labs and Research Institutes

The hospital associated labs segment is assessed to grow significantly during the forecast period. It would make sense for companies to focus on cancer research institutes as collaboration can help in the development of innovative solutions. In this case, companies could think of targeting the APEJ region as it has the highest CAGR during the forecast period. The region spends much less on healthcare as a percentage of GDP than the developed world but strong economic growth will all but ensure that it becomes ever-more important to regional governments in future.

Competition Tracking

Key players in the global market for prostate cancer diagnostics include Abbott Laboratories, Biocept, Inc., AstraZeneca plc., Cancer Genetics, Inc., Danaher Corporation, Bayer Aktiengesellschaft, Becton, Dickinson and Company, Agilent Technologies, Foundation Medicine, Inc., and Myriad Genetics Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1. Global Prostate Cancer Diagnostics Market - Executive Summary. 11

Chapter 2. Global Prostate Cancer Diagnostics Market Overview. 13
2.1. Introduction. 13
       2.1.1. Global Prostate Cancer Diagnostics Market Taxonomy. 13
       2.1.2. Global Prostate Cancer Diagnostics Market Definition. 13
2.2. Global Prostate Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 14
       2.2.1. Global Prostate Cancer Diagnostics Market Y-o-Y Growth. 14
2.3. Global Prostate Cancer Diagnostics Market Dynamics. 14
       2.3.1. Drivers. 14
       2.3.2. Restraints. 14
       2.3.3. Trends. 15
2.4. Supply Chain. 15
2.5. Epidemiology. 15
2.6. Key Participants Market Presence (Intensity Map) By Region. 15

Chapter 3. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Test Type. 16
3.1. Global Prostate Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022. 16
       3.1.1. PSA Tests Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 16
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 16
                3.1.1.2. Market Share Comparison, By Region. 18
                3.1.1.3. Y-o-Y growth Comparison, By Region. 18
       3.1.2. CTC Tests Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 19
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 19
                3.1.2.2. Market Share Comparison, By Region. 21
                3.1.2.3. Y-o-Y growth Comparison, By Region. 21
       3.1.3. Immunohistochemistry Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 22
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 22
                3.1.3.2. Market Share Comparison, By Region. 24
                3.1.3.3. Y-o-Y growth Comparison, By Region. 24
       3.1.4. PCA3 test Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 25
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 25
                3.1.4.2. Market Share Comparison, By Region. 27
                3.1.4.3. Y-o-Y growth Comparison, By Region. 27
       3.1.5. Others Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 28
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 28
                3.1.5.2. Market Share Comparison, By Region. 30
                3.1.5.3. Y-o-Y growth Comparison, By Region. 30

Chapter 4. Global Prostate Cancer Diagnostics Market Analysis and Forecast By End User. 32
4.1. Global Prostate Cancer Diagnostics Market Size and Forecast By End User, 2012-2022. 32
       4.1.1. Hospital Associated Labs Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 32
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 32
                4.1.1.2. Market Share Comparison, By Region. 34
                4.1.1.3. Y-o-Y growth Comparison, By Region. 34
       4.1.2. Independent Diagnostic Laboratories Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 35
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 35
                4.1.2.2. Market Share Comparison, By Region. 37
                4.1.2.3. Y-o-Y growth Comparison, By Region. 37
       4.1.3. Cancer Research Institutes Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 38
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 38
                4.1.3.2. Market Share Comparison, By Region. 40
                4.1.3.3. Y-o-Y growth Comparison, By Region. 40
       4.1.4. Others Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 41
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 41
                4.1.4.2. Market Share Comparison, By Region. 43
                4.1.4.3. Y-o-Y growth Comparison, By Region. 43

Chapter 5. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Region. 45
5.1. Global Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 45
       5.1.1. North America Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 45
                5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 45
                5.1.1.2. Revenue (US$ Mn) Comparison, By End User. 46
       5.1.2. Latin America Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 48
                5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 48
                5.1.2.2. Revenue (US$ Mn) Comparison, By End User. 50
       5.1.3. Europe Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 52
                5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 52
                5.1.3.2. Revenue (US$ Mn) Comparison, By End User. 53
       5.1.4. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 55
                5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 55
                5.1.4.2. Revenue (US$ Mn) Comparison, By End User. 57
       5.1.5. APEJ Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 58
                5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 58
                5.1.5.2. Revenue (US$ Mn) Comparison, By End User. 60
       5.1.6. MEA Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 62
                5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 62
                5.1.6.2. Revenue (US$ Mn) Comparison, By End User. 63

Chapter 6. North America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 66
6.1. US Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 66
       6.1.1. Revenue (US$ Mn) Comparison, By Test Type. 66
       6.1.2. Revenue (US$ Mn) Comparison, By End User. 67
6.2. Canada Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 68
       6.2.1. Revenue (US$ Mn) Comparison, By Test Type. 68
       6.2.2. Revenue (US$ Mn) Comparison, By End User. 69
Chapter 7. Latin America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 70
7.1. Brazil Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 70
       7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 70
       7.1.2. Revenue (US$ Mn) Comparison, By End User. 71
7.2. Mexico Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 72
       7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 72
       7.2.2. Revenue (US$ Mn) Comparison, By End User. 73
7.3. Argentina Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 74
       7.3.1. Revenue (US$ Mn) Comparison, By Test Type. 74
       7.3.2. Revenue (US$ Mn) Comparison, By End User. 75

Chapter 8. Europe Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 76
8.1. Germany Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 76
       8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 76
       8.1.2. Revenue (US$ Mn) Comparison, By End User. 77
8.2. UK Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 78
       8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 78
       8.2.2. Revenue (US$ Mn) Comparison, By End User. 79
8.3. France Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 80
       8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 80
       8.3.2. Revenue (US$ Mn) Comparison, By End User. 81
8.4. Spain Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 82
       8.4.1. Revenue (US$ Mn) Comparison, By Test Type. 82
       8.4.2. Revenue (US$ Mn) Comparison, By End User. 83
8.5. Italy Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 84
       8.5.1. Revenue (US$ Mn) Comparison, By Test Type. 84
       8.5.2. Revenue (US$ Mn) Comparison, By End User. 85
8.6. Nordic Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 86
       8.6.1. Revenue (US$ Mn) Comparison, By Test Type. 86
       8.6.2. Revenue (US$ Mn) Comparison, By End User. 87

Chapter 9. Japan Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 88
9.1. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 88
       9.1.1. Revenue (US$ Mn) Comparison, By Test Type. 88
       9.1.2. Revenue (US$ Mn) Comparison, By End User. 89

Chapter 10. APEJ Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 90
10.1. China Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 90
       10.1.1. Revenue (US$ Mn) Comparison, By Test Type. 90
       10.1.2. Revenue (US$ Mn) Comparison, By End User. 91
10.2. India Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 92
       10.2.1. Revenue (US$ Mn) Comparison, By Test Type. 92
       10.2.2. Revenue (US$ Mn) Comparison, By End User. 93
10.3. Malaysia Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 94
       10.3.1. Revenue (US$ Mn) Comparison, By Test Type. 94
       10.3.2. Revenue (US$ Mn) Comparison, By End User. 95
10.4. Thailand Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 96
       10.4.1. Revenue (US$ Mn) Comparison, By Test Type. 96
       10.4.2. Revenue (US$ Mn) Comparison, By End User. 97
10.5. Singapore Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 98
       10.5.1. Revenue (US$ Mn) Comparison, By Test Type. 98
       10.5.2. Revenue (US$ Mn) Comparison, By End User. 99
10.6. Australia Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 100
       10.6.1. Revenue (US$ Mn) Comparison, By Test Type. 100
       10.6.2. Revenue (US$ Mn) Comparison, By End User. 101

Chapter 11. MEA Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022. 102
11.1. GCC Countries Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 102
       11.1.1. Revenue (US$ Mn) Comparison, By Test Type. 102
       11.1.2. Revenue (US$ Mn) Comparison, By End User. 103
11.2. South Africa Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 104
       11.2.1. Revenue (US$ Mn) Comparison, By Test Type. 104
       11.2.2. Revenue (US$ Mn) Comparison, By End User. 105
11.3. Nigeria Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 106
       11.3.1. Revenue (US$ Mn) Comparison, By Test Type. 106
       11.3.2. Revenue (US$ Mn) Comparison, By End User. 107
11.4. Israel Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 108
       11.4.1. Revenue (US$ Mn) Comparison, By Test Type. 108
       11.4.2. Revenue (US$ Mn) Comparison, By End User. 109

Chapter 12. Global Prostate Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections. 110
12.1. Abbott Laboratories. 110
       12.1.1. Company Overview. 110
       12.1.2. Product Overview. 110
       12.1.3. Key Financials. 110
       12.1.4. Key Developments. 111
       12.1.5. SWOT Analysis. 111
12.2. AstraZeneca plc.. 112
       12.2.1. Company Overview. 112
       12.2.2. Product Overview. 112
       12.2.3. Key Financials. 112
       12.2.4. Key Developments. 112
       12.2.5. SWOT Analysis. 113
12.3. Bayer Aktiengesellschaft. 116
       12.3.1. Company Overview. 116
       12.3.2. Product Overview. 116
       12.3.3. Key Financials. 116
       12.3.4. Key Developments. 117
       12.3.5. SWOT Analysis. 117
12.4. Danaher Corporation. 120
       12.4.1. Company Overview. 120
       12.4.2. Product Overview. 120
       12.4.3. Key Financials. 121
       12.4.4. Key Developments. 121
       12.4.5. SWOT Analysis. 121
12.5. Becton, Dickinson and Company. 124
       12.5.1. Company Overview. 124
       12.5.2. Product Overview. 124
       12.5.3. Key Financials. 125
       12.5.4. Key Developments. 125
       12.5.5. SWOT Analysis. 125
12.6. Foundation Medicine, Inc.. 128
       12.6.1. Company Overview. 128
       12.6.2. Product Overview. 128
       12.6.3. Key Financials. 128
12.7. Cancer Genetics, Inc.. 129
       12.7.1. Company Overview. 129
       12.7.2. Product Overview. 129
       12.7.3. Key Financials. 129
       12.7.4. Key Developments. 130
12.8. Myriad Genetics Inc.. 131
       12.8.1. Company Overview. 131
       12.8.2. Product Overview. 131
       12.8.3. Key Financials. 132
       12.8.4. Key Developments. 132
       12.8.5. SWOT Analysis. 132
12.9. Agilent Technologies. 135
       12.9.1. Company Overview. 135
       12.9.2. Product Overview. 135
       12.9.3. Key Financials. 136
       12.9.4. Key Developments. 136
       12.9.5. SWOT Analysis. 136
12.10. Biocept, Inc.. 137
       12.10.1. Company Overview. 137
       12.10.2. Product Overview. 137
       12.10.3. Key Financials. 137
       12.10.4. Key Developments. 138

Chapter 13. Disclaimer and Contact information. 139

TABLE 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2012-2016 22
TABLE 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2017-2022 23
TABLE 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 25
TABLE 4 Global PSA Tests Segment Value (US$ Mn), By Region 2012-2016 27
TABLE 5 Global PSA Tests Segment Value (US$ Mn), By Region 2017-2022 28
TABLE 6 Global PSA Tests Segment Market Share, By Region 2012-2016 29
TABLE 7 Global PSA Tests Segment Market Share, By Region 2017-2022 29
TABLE 8 Global PSA Tests Segment Y-o-Y, By Region 2015-2022 29
TABLE 9 Global CTC Tests Segment Value (US$ Mn), By Region 2012-2016 30
TABLE 10 Global CTC Tests Segment Value (US$ Mn), By Region 2017-2022 31
TABLE 11 Global CTC Tests Segment Market Share, By Region 2012-2016 32
TABLE 12 Global CTC Tests Segment Market Share, By Region 2017-2022 32
TABLE 13 Global CTC Tests Segment Y-o-Y, By Region 2015-2022 32
TABLE 14 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2012-2016 33
TABLE 15 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2017-2022 34
TABLE 16 Global Immunohistochemistry Segment Market Share, By Region 2012-2016 35
TABLE 17 Global Immunohistochemistry Segment Market Share, By Region 2017-2022 35
TABLE 18 Global Immunohistochemistry Segment Y-o-Y, By Region 2015-2022 35
TABLE 19 Global PCA3 test Segment Value (US$ Mn), By Region 2012-2016 36
TABLE 20 Global PCA3 test Segment Value (US$ Mn), By Region 2017-2022 37
TABLE 21 Global PCA3 test Segment Market Share, By Region 2012-2016 38
TABLE 22 Global PCA3 test Segment Market Share, By Region 2017-2022 38
TABLE 23 Global PCA3 test Segment Y-o-Y, By Region 2015-2022 38
TABLE 24 Global Others Segment Value (US$ Mn), By Region 2012-2016 39
TABLE 25 Global Others Segment Value (US$ Mn), By Region 2017-2022 40
TABLE 26 Global Others Segment Market Share, By Region 2012-2016 41
TABLE 27 Global Others Segment Market Share, By Region 2017-2022 41
TABLE 28 Global Others Segment Y-o-Y, By Region 2015-2022 41
TABLE 29 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2012-2016 43
TABLE 30 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2022 44
TABLE 31 Global Hospital Associated Labs Segment Market Share, By Region 2012-2016 45
TABLE 32 Global Hospital Associated Labs Segment Market Share, By Region 2017-2022 45
TABLE 33 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2022 45
TABLE 34 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2012-2016 46
TABLE 35 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2022 47
TABLE 36 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2012-2016 48
TABLE 37 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2022 48
TABLE 38 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2022 48
TABLE 39 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2012-2016 49
TABLE 40 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2022 50
TABLE 41 Global Cancer Research Institutes Segment Market Share, By Region 2012-2016 51
TABLE 42 Global Cancer Research Institutes Segment Market Share, By Region 2017-2022 51
TABLE 43 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2022 51
TABLE 44 Global Others Segment Value (US$ Mn), By Region 2012-2016 52
TABLE 45 Global Others Segment Value (US$ Mn), By Region 2017-2022 53
TABLE 46 Global Others Segment Market Share, By Region 2012-2016 54
TABLE 47 Global Others Segment Market Share, By Region 2017-2022 54
TABLE 48 Global Others Segment Y-o-Y, By Region 2015-2022 54
TABLE 49 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 56
TABLE 50 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 56
TABLE 51 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 57
TABLE 52 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 58
TABLE 53 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 59
TABLE 54 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 60
TABLE 55 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 61
TABLE 56 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 61
TABLE 57 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 63
TABLE 58 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 63
TABLE 59 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 64
TABLE 60 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 65
TABLE 61 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 66
TABLE 62 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 67
TABLE 63 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 68
TABLE 64 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 68
TABLE 65 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 69
TABLE 66 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 70
TABLE 67 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 71
TABLE 68 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 72
TABLE 69 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 73
TABLE 70 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 73
TABLE 71 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 74
TABLE 72 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 75
TABLE 73 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 77
TABLE 74 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 77
TABLE 75 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 78
TABLE 76 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 78
TABLE 77 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 79
TABLE 78 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 79
TABLE 79 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 80
TABLE 80 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 80
TABLE 81 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 81
TABLE 82 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 81
TABLE 83 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 82
TABLE 84 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 82
TABLE 85 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 83
TABLE 86 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 83
TABLE 87 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 84
TABLE 88 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 84
TABLE 89 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 85
TABLE 90 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 85
TABLE 91 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 86
TABLE 92 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 86
TABLE 93 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 87
TABLE 94 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 87
TABLE 95 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 88
TABLE 96 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 88
TABLE 97 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 89
TABLE 98 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 89
TABLE 99 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 90
TABLE 100 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 90
TABLE 101 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 91
TABLE 102 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 91
TABLE 103 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 92
TABLE 104 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 92
TABLE 105 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 93
TABLE 106 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 93
TABLE 107 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 94
TABLE 108 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 94
TABLE 109 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 95
TABLE 110 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 95
TABLE 111 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 96
TABLE 112 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 96
TABLE 113 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 97
TABLE 114 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 97
TABLE 115 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 98
TABLE 116 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 98
TABLE 117 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 99
TABLE 118 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 99
TABLE 119 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 100
TABLE 120 Japan  Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 100
TABLE 121 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 101
TABLE 122 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 101
TABLE 123 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 102
TABLE 124 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 102
TABLE 125 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 103
TABLE 126 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 103
TABLE 127 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 104
TABLE 128 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 104
TABLE 129 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 105
TABLE 130 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 105
TABLE 131 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 106
TABLE 132 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 106
TABLE 133 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 107
TABLE 134 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 107
TABLE 135 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 108
TABLE 136 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 108
TABLE 137 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 109
TABLE 138 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 109
TABLE 139 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 110
TABLE 140 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 110
TABLE 141 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 111
TABLE 142 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 111
TABLE 143 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 112
TABLE 144 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 112
TABLE 145 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 113
TABLE 146 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 113
TABLE 147 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 114
TABLE 148 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 114
TABLE 149 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 115
TABLE 150 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 115
TABLE 151 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 116
TABLE 152 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 116
TABLE 153 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 117
TABLE 154 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 117
TABLE 155 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 118
TABLE 156 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 118
TABLE 157 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 119
TABLE 158 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 119
TABLE 159 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 120
TABLE 160 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 120

 

FIG. 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2012-2016 15
FIG. 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2022 15
FIG. 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 17
FIG. 4 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2012-2016 19
FIG. 5 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2017-2022 20
FIG. 6 Global PSA Tests Segment Y-o-Y Growth Rate, By Region, 2015-2022 22
FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2012-2016 22
FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2017-2022 23
FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2015-2022 25
FIG. 10 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2012-2016 25
FIG. 11 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2017-2022 26
FIG. 12 Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2015-2022 28
FIG. 13 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2012-2016 28
FIG. 14 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2017-2022 29
FIG. 15 Global PCA3 test Segment Y-o-Y Growth Rate, By Region, 2015-2022 31
FIG. 16 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 31
FIG. 17 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 32
FIG. 18 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 34
FIG. 19 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2012-2016 35
FIG. 20 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2022 36
FIG. 21 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2022 38
FIG. 22 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016 38
FIG. 23 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022 39
FIG. 24 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022 41
FIG. 25 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016 41
FIG. 26 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022 42
FIG. 27 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022 44
FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 44
FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 45
FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 47
FIG. 31 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 48
FIG. 32 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 49
FIG. 33 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 50
FIG. 34 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 50
FIG. 35 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 51
FIG. 36 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 52
FIG. 37 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 53
FIG. 38 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 54
FIG. 39 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 55
FIG. 40 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 56
FIG. 41 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 57
FIG. 42 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 57
FIG. 43 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 58
FIG. 44 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 59
FIG. 45 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 60
FIG. 46 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 61
FIG. 47 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 62
FIG. 48 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 62
FIG. 49 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 63
FIG. 50 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 64
FIG. 51 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 65
FIG. 52 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 66
FIG. 53 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 67
FIG. 54 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 67

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development